| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 7 |
| 1 | METHOTREXATE | 6 |
| 2 | METHYLPREDNISOLONE | 6 |
| 3 | ANAKINRA | 5 |
| 4 | AZATHIOPRINE | 5 |
| 5 | CANAKINUMAB | 5 |
| 6 | GOLIMUMAB | 5 |
| 7 | PREDNISONE | 5 |
| 8 | TOCILIZUMAB | 5 |
| 9 | CARFILZOMIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAKINUMAB | 5 | 0.0005 |
| 1 | GOLIMUMAB | 5 | 0.0004 |
| 2 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| 3 | CLINDAMYCIN PHOSPHATE | 2 | 0.0004 |
| 4 | ANAKINRA | 5 | 0.0003 |
| 5 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 6 | CARFILZOMIB | 4 | 0.0001 |
| 7 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 8 | TOLTERODINE TARTRATE | 1 | 0.0001 |
| 9 | NEVIRAPINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 4 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkaloid [EPC] | 1 | 0.0000 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 5 | 0.0000 |
| 8 | Proteasome Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |